Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.00 | -22.08 |
PEG Ratio (TTM) | -0.07 | 15.66 |
P/S Ratio (TTM) | 0.54 | 49.38 |
P/B Ratio (TTM) | 0.43 | 18.85 |
P/FCF Ratio (TTM) | 30.29 | -3.07 |
Price to 5YR AVG Earnings Ratio | -0.01 | -3.42 |
Price to 5YR AVG FCF Ratio | -0.19 | -9.04 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -12.24% | -5.15% |
ROE (TTM) | -14.74% | 16.37% |
Net Profit Margin (TTM) | -17.73% | -2,030.32% |
ROIC 5YR AVG | 1,814.70% | 15.65% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 25.11% | 22.54% | 44.26% |
Revenue | 3,794.50% | 77.76% | 373.43% |
Net Income | 19.35% | -43.09% | -1.82% |
Cash Flow | 29.70% | -347.71% | -183.81% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.98 | 6.19 |
Quick Ratio (TTM) | 6.65 | 5.91 |
D/E Ratio (TTM) | N/A | -15.10 |
Interest Coverage (TTM) | -1,009.50 | -1.60 |
Piotroski F-Score | 4 | 5 |
Altman Z-Score | N/A | 14.02 |
LTL to 5YR AVG FCF | N/A | 0.18 |
Shares Outstanding Growth 5YR AVG | 220.67% | 123.85% |